RTW Biotech Opportunities Ltd
RTWFF
$1.66
-$0.09-5.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 936.90% | 936.90% | 132.83% | 132.83% | 52.24% |
| Total Revenue | 936.90% | 936.90% | 132.83% | 132.83% | 52.24% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 936.90% | 936.90% | 132.83% | 132.83% | 52.24% |
| SG&A Expenses | 19.12% | 19.12% | 79.48% | 79.48% | 58.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.88% | 23.88% | 82.26% | 82.26% | 56.87% |
| Operating Income | 972.22% | 972.22% | 2.19% | 2.19% | -62.22% |
| Income Before Tax | -147.46% | -147.46% | -201.86% | -201.86% | 164.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -147.46% | -147.46% | -201.86% | -201.86% | 164.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -147.46% | -147.46% | -201.86% | -201.86% | 164.15% |
| EBIT | 972.22% | 972.22% | 2.19% | 2.19% | -62.22% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -148.28% | -148.28% | -163.87% | -163.87% | 67.06% |
| Normalized Basic EPS | -77.59% | -77.59% | -30.18% | -30.18% | 966.67% |
| EPS Diluted | -148.28% | -148.28% | -163.87% | -163.87% | 67.06% |
| Normalized Diluted EPS | -77.59% | -77.59% | -30.18% | -30.18% | 966.67% |
| Average Basic Shares Outstanding | -1.68% | -1.68% | 59.38% | 59.38% | 58.07% |
| Average Diluted Shares Outstanding | -1.68% | -1.68% | 59.38% | 59.38% | 58.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |